FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the use of a compound of formula I
for the manufacture of a medicinal product for the prevention and/or treatment of a disease or condition in an animal caused by or associated with a pathogenic infection, where the pathogen is the feline infectious peritonitis virus, also includes the use of a compound of formula I
for the manufacture of a product against a pathogenic infection in an animal, where the pathogen is the feline infectious peritonitis virus.
EFFECT: group of inventions provides a significant improvement in survival of animals infected with feline infectious peritonitis virus, improves their appetite, mental state, weight, and provides a significant extension of the survival period of animals.
10 cl, 2 ex, 2 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
LUNG CELLS OF COTTON RATS FOR CULTIVATION OF VIRUSES | 2003 |
|
RU2376370C2 |
PREPARATION FOR TREATMENT AND PROPHYLAXIS OF SICKNESS IN MAMMALS, BIRDS AND REPTILES | 1997 |
|
RU2093177C1 |
DRY VACCINE COMPOSITIONS STABLE AT ROOM TEMPERATURE | 2014 |
|
RU2826263C2 |
VACCINES, STABLE AT ROOM TEMPERATURE | 2014 |
|
RU2740920C2 |
PRODUCING POULTRY AND OTHER ANIMALS RESISTANT TO VIRAL DISEASES | 2006 |
|
RU2533804C2 |
EMULSION VACCINE PRODUCED FROM HEATED BACTERIN | 2011 |
|
RU2569457C2 |
PRIME-BOOST VACCINATION SCHEDULE | 2019 |
|
RU2817873C2 |
STABILISED VACCINE COMPOSITION FOR STIMULATION OF IMMUNE RESPONSE AND METHOD FOR ITS OBTAINING | 2003 |
|
RU2339400C2 |
SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES | 1999 |
|
RU2270864C2 |
ASSOCIATED WITH PARAINFLUENZA-3 VACCINE, INFECTIOUS RHINOTRACHEITIS, VIRAL DIARRHEA, ROTA- AND CORONAVIRAL INFECTIONS OF CATTLE INACTIVATED EMULSION | 2018 |
|
RU2696007C1 |
Authors
Dates
2023-12-18—Published
2021-06-11—Filed